Pharmaleads (France)

Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes

Ahcène Hameg, Franck Baylé, Philippe Nuss et al. · Biochemical Pharmacology · 2003 · 185 citations · Full text

Human Recombinant Dopamine, Anxiolytic Antipsychotic Drug, Psychoactive Drug +12

Immunosuppressive role of semaphorin‐3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization

Yves Lepelletier, Ivan Cruz Moura, Réda Hadj‐Slimane et al. · European Journal of Immunology · 2006 · 177 citations · Full text

Evaluation of Matrix Metalloproteinases in Atherosclerosis Using a Novel Noninvasive Imaging Approach

Eric Lancelot, Vardan Amirbekian, Irène Brigger et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 148 citations · Full text

Phase I Trial of Sorafenib in Combination with IFN α-2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma

Bernard Escudier, Nathalie Lassau, Eric Angevin et al. · Clinical Cancer Research · 2007 · 140 citations

Fear-avoidance beliefs about back pain in patients with subacute low back pain

Serge Poiraudeau, François Rannou, Gabriel Baron et al. · Pain · 2006 · 129 citations

Pain Therapy, Physical Activity, Pain Medicine +17